Stock Events

Precipio 

$5.5
38
+$1.15+26.44% Wednesday 20:00

Statistics

Day High
5.8
Day Low
4.64
52W High
8.99
52W Low
4.31
Volume
73,742
Avg. Volume
6,317
Mkt Cap
8.08M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

15MayExpected
Q2 2022
Q3 2022
Q4 2022
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-1.4
-0.64
0.12
0.88
Expected EPS
N/A
Actual EPS
0.6514

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PRPO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Health Technology
Biotechnology
Manufacturing
Analytical Laboratory Instrument Manufacturing
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
Show more...
CEO
Paul Kinnon
Employees
51
Country
US
ISIN
US74019L5030
WKN
000A2PH8V

Listings